Oruka Therapeutics CMO Disposes $462,829 in Stock as Analysts Lift Targets on ORKA-001 Progress
Oruka Therapeutics' Chief Medical Officer, Joana Goncalves, sold 7,000 shares on April 15, 2026, for about $462,829 under a Rule 10b5-1 plan she set last September, while simultaneously exercising options to acquire 7,000 shares. The stock is trading near its 52-week high after a steep 666% annual gain and draws mixed signals - heavy analyst optimi…